MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Widespread White Matter Changes in Manifest Huntington’s Disease

    S. Zadegan, TM. Cordeiro, E. Furr Stimming, A. Teixeira, N. Rocha (San Antonio, USA)

    Objective: To characterize white matter changes in Huntington’s Disease (HD). Background: HD is a genetic neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms. Diffusion Tensor…
  • 2025 International Congress

    Hyperkinetic Movement Disorder associated with Papillary Thyroid Carcinoma

    U. Agarwal, R. Al-Hader, S. Fu, Z. Farzal, M. Cerghet (Detroit, USA)

    Objective: To describe a case of hyperkinetic movement disorder associated with papillary thyroid carcinoma, highlighting the diagnostic workup and therapeutic interventions. Background: Paraneoplastic neurological syndromes…
  • 2025 International Congress

    Huntington’s Disease: Overview from 20 Years of a Single-Center Experience

    M. Tsalta-Mladenov, M. Levkova, M. Hachmeriyan, L. Angelova (Varna, Bulgaria)

    Objective: This study evaluates patient data from individuals with Huntington’s disease who attended our single tertiary center. Background: Huntington’s disease is an inherited neurodegenerative disorder…
  • 2025 International Congress

    Blood-based somatic CAG repeat expansion and clinical progression in Huntington’s disease patients from Western China

    SR. Zhang, YF. Cheng, CY. Li, HF. Shang (Chengdu, China)

    Objective: To investigate the association between blood-based somatic CAG repeat expansion ratio (SER) and clinical characteristics in Huntington’s disease (HD) patients from Western China. Background:…
  • 2025 International Congress

    The Unlikely Treatable A Case of Ataxia

    V. Quintana, S. Bonilla, L. Carvajal, J. Nastasi Catanese, . , . (Cali, Colombia)

    Objective: To present the first reported Colombian case in a patient presenting COQ8A-ataxia with bilateral palpebral ptosis, who had a favorable response to CoQ10 supplementation…
  • 2025 International Congress

    Safety and Efficacy of a Wrist-Worn Vibratory Stimulator for Upper Limb Tremor Reduction in Essential Tremor (ULTRE): A Randomized, Controlled Trial

    F. Nahab, H. Kim, S. Nekkanti, A. Davanzo, D. Carballo, K. Winterfeldt, L. Shih, R. Elble (La Jolla, USA)

    Objective: To assess the safety, tolerability, and efficacy of a wrist-worn vibratory stimulator by comparing two active paradigms (Pulsed (AP), Continuous (AC)) to Sham in…
  • 2025 International Congress

    Effects of transcutaneous periodic vibratory stimulation on gait and balance function in Spinocerebellar degeneration -a pilot study

    N. Togashi, S. Kubokawa, K. Minemura, K. Tateno, Y. Miyagi, A. Kawanami, K. Hasegawa (Sagamihara, Japan)

    Objective: The aim of this study is to clarify the efficacy of transcutaneous periodic vibrational stimulation(TPVS)on gait and balance function in patients with spinocerebellar degeneration…
  • 2025 International Congress

    Co-occurrence of Spinal Muscular Atrophy Type 2 and Huntington’s Disease

    U. Agarwal, S. Fu, Y. Wang, B. Bulica (Detroit, USA)

    Objective: To describe a unique case of co-occurring SMA2 and HD in a patient. Background: Huntington’s Disease (HD) is an autosomal dominant neurodegenerative disorder caused…
  • 2025 International Congress

    Novel findings in a Swedish RFC1-related disorder cohort

    V. Alm, L. Verrecchia, M. Paucar (Huddinge, Sweden)

    Objective: This study aims to clinically characterize a Swedish cohort of patients featuring RFC1 CANVAS/spectrum disorders. Background: Biallelic pentanucleotide expansions in the RFC1 gene are…
  • 2025 International Congress

    Huntington disease in a Patient with Extensive Psychiatric History

    A. Sim, A. Drozdov, D. Carrillo, L. Acosta (El Paso, USA)

    Objective: Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder resulting from an expansion of CAG trinucleotide repeats in the gene encoding the huntingtin protein.…
  • « Previous Page
  • 1
  • …
  • 221
  • 222
  • 223
  • 224
  • 225
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley